Diabetes Drug Focus of New Clinical Trial for Parkinson


(September 7, 2016) - Type II diabetes and Parkinson's disease may share important molecular similarities that provide a potential target for fighting Parkinson's. These commonalities form the foundation of a clinical trial now underway at Cedars-Sinai in Los Angeles to investigate the use of the diabetes drug liraglutide to slow or stop the progression of Parkinson's. Read more…

Click for a printer friendly version

Back to top